arrow
M

Michael A. Curran

The University of Texas MD Anderson Cancer Center
H指数:48
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways

STING激活通过炎症性细胞死亡通路诱导脑膜瘤中的细胞毒性及免疫反应

2026-02-120
OAAI
Synergistic STING activation in meningioma neoplastic and immune populations triggers programmed necrosis and modulates the collagen-rich immunosuppressive microenvironment

在脑膜瘤的肿瘤和免疫细胞群体中,协同的STING激活会触发程序性坏死并调节富含胶原的免疫抑制性微环境。

2025-11-010
OAAI
Sickle cell disease induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity

镰状细胞病诱导CD8+ T细胞发生染色质内卷和铁死亡,以抑制抗肿瘤免疫。

Immunity
IF26.3
2025-05-120
OA
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial (vol 30, pg 807, 2024)

基因组生物标志物预测阿替利珠单抗联合贝伐珠单抗免疫治疗在肝细胞癌中的疗效:来自IMbrave150试验的见解(卷30,页807,2024)

2025-02-270
OA
THERAPEUTIC TARGETING OF STING IN MENINGIOMAS
2024-11-110
PRE
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
2024-06-174
OAAI